CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,263
- in 2 filings
Net −$22,263. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-12-29 | CHESS ROBERT Director | Sale | −29,500 | $15.34 | $453K | 260,623 |
| 2014-12-29 | CHESS ROBERT Director | Exercise or conversion · Stock Option | −29,500 | 0 | ||
| 2014-12-22 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion | +5,000 | $11.38 | $57K | 7,999 |
| 2014-12-22 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −5,000 | $15.56 | $78K | 2,999 |
| 2014-12-22 | Thomsen Jillian B. SVP & Chief Accounting Officer | Exercise or conversion · Stock Option | −5,000 | 0 | ||
| 2014-12-09 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +225,000 | 225,000 | ||
| 2014-12-09 | ROBIN HOWARD W President & CEO | Grant or award · Stock Option | +225,000 | 225,000 | ||
| 2014-12-09 | Nicholson John SVP & Chief Financial Officer | Grant or award · Stock Option | +87,500 | 87,500 | ||
| 2014-12-09 | Nicholson John SVP & Chief Financial Officer | Grant or award · Stock Option | +87,500 | 87,500 | ||
| 2014-12-09 | Labrucherie Gil M SVP & General Counsel | Grant or award · Stock Option | +87,500 | 87,500 | ||
| 2014-12-09 | Labrucherie Gil M SVP & General Counsel | Grant or award · Stock Option | +87,500 | 87,500 | ||
| 2014-12-09 | Hora Maninder SVP Pharma Dev & Mfg Ops | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2014-12-09 | Hora Maninder SVP Pharma Dev & Mfg Ops | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2014-12-09 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2014-12-09 | Gergel Ivan P. SVP & Chief Medical Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2014-12-09 | Doberstein Stephen K SVP & Chief Scientific Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2014-12-09 | Doberstein Stephen K SVP & Chief Scientific Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2014-12-09 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2014-12-09 | Thomsen Jillian B. SVP & Chief Accounting Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2014-12-01 | Labrucherie Gil M SVP & General Counsel | Exercise or conversion | +30,000 | $4.65 | $140K | 34,251 |
Page 64 of 69 · 1,361 trades